Table 3 Characteristics of 48 patients with metastatic prostate cancer
Variables | Median (range, mean ± SD) |
|---|---|
Age (y) | 70.5 (51–88, 71.33 ± 6.92) |
Initial PSA (ng/mL) | 82.16 (8.2–7285, 605.06 ± 1446.25) |
Pathological Grade | |
Gleason Score ≤ 6 | 2 (4.2 %) |
Gleason Score = 7 | 14 (29.2 %) |
Gleason Score ≥ 8 | 32 (66.7 %) |
Clinical T Stage | |
2 | 6 (12.5 %) |
3 | 27 (56.3 %) |
4 | 15 (31.3 %) |
Clinical N Stage | |
0 | 21 (43.8 %) |
1 | 27 (56.3 %) |
Clinical M Stage | |
0 | 13 (27.1 %) |
1 | 35 (72.9 %) |
NLR | 2.49 (0.84–10.56, 2.93 ± 1.66) |